CAPPED BONUS CERTIFICATE - SARTORIUS STEDIM BIO Stock

Certificat

C374S

FRSGE001OO51

Real-time Euronext Paris 05:13:49 2024-05-21 am EDT
221.9 EUR +0.19% Intraday chart for CAPPED BONUS CERTIFICATE - SARTORIUS STEDIM BIO
Current month-0.84%
1 month+1.96%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 221.9 +0.19%
24-05-20 221.4 -0.10%
24-05-17 221.7 -2.09%
24-05-16 226.4 -3.24%
24-05-15 234 +0.71%

Real-time Euronext Paris

Last update May 21, 2024 at 05:13 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
C374S
ISINFRSGE001OO51
Date issued 2023-11-15
Strike 262
Maturity 2024-12-20 (214 Days)
Parity 1 : 1
Emission price 189.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 245.4
Lowest since issue 195.3
Spread 0.44
Spread %0.20%

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
195.6 EUR
Average target price
250.1 EUR
Spread / Average Target
+27.82%
Consensus
  1. Stock Market
  2. Certificates
  3. C374S Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW